PWP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Perella Weinberg Partners is not a strong buy at the moment for a beginner investor with a long-term strategy. The lack of positive trading signals, weak financial performance, and mixed analyst ratings suggest holding off on investment until more favorable conditions arise.
The MACD histogram is positive at 0.162, indicating slight bullish momentum, but it is contracting. The RSI is neutral at 54.62, and moving averages are converging, showing no clear trend. The stock is trading near support levels (S1: 20.013), with resistance at 21.262. Overall, technical indicators suggest a neutral stance.
Keefe Bruyette recently upgraded the stock to Outperform with a price target of $21, citing potential strength in large-cap M&A activity. The upcoming Q1 2026 financial results on May 1, 2026, could provide clarity on the company's performance and future direction.
Hedge funds are selling the stock, with a 126.05% increase in selling activity over the last quarter. Financial performance in Q4 2025 showed significant declines in revenue (-2.89% YoY), net income (-54.77% YoY), and EPS (-76.92% YoY). Analyst ratings are mixed, with Goldman Sachs maintaining a Sell rating and a price target below the current pre-market price.
In Q4 2025, the company reported declining financial metrics, including a revenue drop to $219.16 million (-2.89% YoY), net income falling to $9.396 million (-54.77% YoY), and EPS decreasing to $0.09 (-76.92% YoY). Gross margin remained stable at 100%.
Analyst ratings are mixed. Keefe Bruyette upgraded the stock to Outperform with a price target of $21, while Goldman Sachs maintains a Sell rating with a price target of $19.50. Citizens lowered its price target to $30 but kept an Outperform rating, citing challenges in navigating market volatility.
